We examine expression across normal brain and cancers, evaluate survival associations, map the co-expression and interaction contexts, and ask whether loss of OPCML promotes aggressive phenotypes by releasing PI3K–AKT–mTOR signaling. Here, AKT1 is linked to cancer.